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SUMMARY 
The effectiveness of doses of i.v. cocaine and nomifensine in maintaining 
lever-press responding in rhesus monkeys was evaluated under two schedules, 
fixed- and progressive-ratio (FR, PR). The doses that maintained maximum 
rates of responding under the fixed-ratio schedule were 0.32 mg/kg per injec- 
tion cocaine and 0.10 mg/kg per injection nomifensine. The fixed-ratio rates 
maintained by this dose of nomifensine were slightly lower than those main- 
tained by cocaine. Under the progressive-ratio schedule, the maximum response 
rates developed with 0.32 mg/kg per injection cocaine and 0.32 mg/kg per 
injection nomifensine. Maximum performances under the progressive ratio 
were slightly higher with cocaine than with nomifensine. Taken in conjunc- 
tion with existing data for other drugs and conditions, these data indicate 
that progressive-ratio schedules may yield information on the relative rein- 
forcing effects of drugs that differs only slightly from that obtained with 
fixed-ratio schedules. 
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INTRODUCTION 
While it is relatively easy to determine whether a specific stimulus is a 
positive reinforcer or not, a more extensive and different set of procedures 
is used to determine the relative reinforcing efficacy of different stimuli or 
different amounts of the same stimulus. One procedure for measuring relative 
reinforcing strength is the PR schedule. Here, the number of responses neces- 
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sary to present the reinforcer is increased systematically until a significant 
reduction in rate of responding occurs. The response requirement that cul- 
minates in a low rate of responding is referred to as a ‘breaking point’ and is 
thought to reflect the strength of the reinforcing stimulus. In addition to 
suggesting the use of this schedule, Hodos [l] demonstrated in rats working 
on a PR schedule for milk reinforcement, that increased food deprivation led 
to higher breaking points. Increasing the volume of milk presented as a reward 
also led to increases in the breaking point, up to a certain volume. With higher 
volumes, a decrement in the breaking point was observed, probably due to a 
satiation effect [ 21. 
Progressive-ratio schedules have been used frequently to study the relative 
reinforcing strengths of intravenously delivered drugs. This is particularly 
important in view of the interest in developing evaluation procedures for 
abuse liability of various psychoactive drugs. Griffiths et al. [3] compared 
the ability of cocaine and three anorectic agents to maintain PR behavior 
when administered i.v. in a wide range of doses to baboons. These investigators 
found that the maximally effective dose of the different drugs maintained 
different breaking points (cocaine > diethylpropion > chlorphentermine > 
fenfluramine). Progressive-ratio studies have also been made of narcotic drugs. 
Hoffmeister [ 41, studied the ability of a range of doses of heroin, codeine, 
dextropropoxyphene and pentazocine to maintain behavior on PR schedules. 
Heroin maintained a slightly higher breaking point than codeine, while 
codeine and dextropropoxyphene maintained similar breaking points which 
were slightly higher than that maintained by pentazocine. These determina- 
tions of a single breaking point as described above take considerable periods 
of time. For example, Griffiths et al. [5], increased the ratio on a daily basis 
and, in some cases, a single breaking point determination took 6 days. 
Other investigators have compared abuse liability of drugs in experimental 
studies using the rate of responding on fixed-ratio schedules as the dependent 
measure [ 61. This is perhaps a less complex procedure, and can usually gen- 
erate information more quickly than the progressive-ratio schedules used to 
date. The procedure does differentiate among morphine-like drugs. In our 
laboratory, for example, we have observed that codeine, morphine and 
methadone [ 71 maintain relatively higher rates of responding than nalbuphine 
[81. 
Direct comparisons between the ability of FR and PR schedules to indicate 
the relative reinforcing effects of drugs are rare. Griffiths et al. [ 51, studied 
the ability of cocaine, in a range of doses, to maintain responding on PR and 
FR schedules. They found little difference in the shape of the dose-effect 
curve, or the dose that maintained maximal behavior, either FR rate or PR 
breaking point. They concluded that these two procedures, although method- 
ologically distinct, produced quite similar results. 
In the present study, a similar comparison was made between PR and FR 
schedules using two drugs, cocaine and nomifensine. The schedules had 
markedly different parameters than those used by Griffiths et al. [ 51. Those 
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investigators used a FR value of 160 with a post-injection time out period 
of 3 h. Their PR schedule started at 160 and doubled every 24 h as long as 
behavior was maintained above criterion levels. Again, the time out after each 
injection was 3 h. A much shorter procedure was used in the current study 
in an attempt to demonstrate that PR studies can be done fairly rapidly. A 
similar objective prompted an earlier study [9]. Determinations of the rate- 
maintaining effects of a given dose of a drug under study with the FR pro- 
cedure could be made in a 2-h session. With the PR procedure, a single 
session of less than 8 h was usually sufficient to provide information on the 
breaking point engendered by a specific dose. 
Thus, the objectives of the study were to compare the PR and FR per- 
formances maintained by cocaine under similar conditions, but conditions 
that were somewhat different from those in the literature. A second objective 
was to compare another drug, nomifensine, to cocaine under both schedules. 
This would provide a systematic replication of the cocaine-dose relations 
under the two schedules. We had noted earlier that nomifensine maintained 
self-injection responding in rhesus monkeys [lo]. Subsequently, a similar 
study in rodents appeared [ 111. A quantitative comparison of nomifensine 
to cocaine was of interest under the two schedules. 
METHODS 
Three male rhesus monkeys served as subjects in this experiment. They 
were housed in cages with open fronts, and were restrained in these cages by 
tubular metal harnesses and jointed restraining arms. The restraining harness 
protected the catheter from the monkey. This harness and arm apparatus 
allowed the monkeys relatively free movement within the cages [ 121. The 
cages were equipped with two levers and three stimulus lights [6]. 
Under ketamine and pentobarbital anesthesia, silastic catheters (i.p. 0.08 
cm, o.d. 0.24 cm, Rodhelm Reiss Co. Belle Mead, NJ, U.S.A.) were surgically 
placed in one of either the jugular or femoral veins of the monkeys. These 
veins were catheterized sequentially as catheters became dislodged from 
previous sites. The catheter was routed subcutaneously from the site of inser- 
tion to the midscapular region where it exited from beneath the skin. At this 
location, the catheter was joined to a similar catheter that passed through 
the restraining arm to the outside of the cage. Here it was connected to a 
roller pump (Model MHRK 55, Watson and Marlow Co., Falmouth, U.K.) 
that could be operated remotely. 
There were two sessions each day, the first starting around 1000 h and 
lasting no more than 130 min, the second starting around 1600 h and lasting 
for an indefinite period. In general, when a session began, a red stimulus light 
came on in the cage. Responses on the lever in the presence of the red light 
resulted in an infusion of 0.32 mg/kg cocaine. During the infusion, the red 
light was turned off, and a green light was illuminated. Both lights were off 
after the injection for a specified length of time, and during this time responses 
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had no programmed consequence. At the end of this time-out period, the red 
light was illuminated again, and the cycle was repeated. 
When the monkeys were being trained to make the response, the response 
requirement was set at 1 and gradually increased to 30. Likewise, the post- 
injection time out (TO) was initially just a few seconds, and gradually increased 
to 10 min. Once the monkeys were responding under the conditions of the 
FR 30 TO lo-min schedule at rates in excess of 1 response/s in the presence 
of the red light, the progressive-ratio schedule was initiated in the afternoon 
sessions. In the PR schedule, the first drug infusion was given following 30 
responses and was followed by a lo-min TO. The second infusion was given 
following 60 responses, the third after 90 responses and so on in increments 
of 30. Each injection was followed by a lo-min TO. The maximum number 
of infusions possible during the session was 30, making the maximum response 
requirement 900; thus the session terminated after 30 infusions or if no 
more than two responses were made during a 15-min period with the red 
light on. The last completed fixed-ratio value was designated as the breaking 
point. 
The regular FR 30 TO lo-min schedule continued in the morning session. 
Here, the session terminated after 13 infusions or 130 min. When responding 
was stable in both the morning (FR 30 TO 10 min) and afternoon (PR 30 
TO 10 min) sessions, a change was made in the dose of cocaine during a 
single session, morning or afternoon. The baseline dose was then returned for 
two or three sessions, and then another dose change was made. Typically, a 
series of dose substitutions was made first in the FR sessions, and then in the 
PR sessions. Following completion of the series of cocaine-dose substitutions, 
similar substitutions were made with a series of nomifensine doses. 
In the PR schedule, each dose of cocaine was substituted twice in each 
monkey. With the FR schedule, various doses of cocaine were substituted 
only once in each monkey since comparative data are already available for 
cocaine on FR schedules. With nomifensine, under both schedule conditions, 
each dose was substituted twice. 
The experiments were controlled by a PDP/8e computer (Digital Equip- 
ment Corp., Maynard, MA, U.S.A.). The interface and software (SKED) were 
obtained from State Systems, Inc., Kalamazoo, MI, U.S.A.). The computer 
and cumulative recording equipment were located in a room adjacent to the 
monkey test facility, where a closed circuit TV was also available. 
RESULTS 
Nomifensine and cocaine maintained self-injection behavior on an FR 30 
TO lo-min schedule as shown in Fig. 1. The dose-effect curves for the two 
drugs were quite similar. They took the form of inverted U-shaped functions 
that are frequently reported with drugs that maintain self-administration 
behavior. The primary difference was in the potency of the two compounds. 
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Fig. 1. Rates of FR responding with doses of cocaine nomifensine or saline (SAL). The 
legend at the right side of the figure gives the codes for the individual monkey data as 
well as the averaged data for each drug, 
kg per injection. Nomifensine maintained a peak rate of responding at 3.06 
responses/s at a dose of 0.10 mg/kg per injection. Nomifensine thus was % 
log unit more potent than cocaine in the FR procedure. 
Although no time limit was set on the PR session, the monkeys usually 
responded at high rates or responded very little; thus sessions never lasted 
longer than 7 h. With the PR schedule, both cocaine and nomifensine main- 
tamed maximum breaking points at a dose of 0.32 mg/kg per injection. A 


























Fig. 2. Breaking points for responding maintained by saline (SAL), nomifensine or co- 
caine. The legend at the right side of the figure gives the codes for the individual monkey 
data as well as the averaged data for each drug. Dot, compsimpratio; disk, gdw. 
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solve in water at the concentrations that would have been necessary to test 
this dose. It is likely that the breaking point at 1.0 mg/kg per injection nomi- 
fensine would have been decreased relative to that at 0.32 mg/kg per injection 
since two of the three monkeys showed slight decreases in breaking point 
from 0.10 to 0.32 mg/kg per injection. The fact that average rates increased 
over this dose range is due to one monkey who had quite a low breaking 
point at the 0.10 mg/kg per injection dose, and a very high breaking point at 
the 0.32 mg/kg per injection dose. 
DISCUSSION 
Both cocaine and nomifensine maintained self-injection responding under 
both schedules of drug delivery. The doses of drug were strong determinants 
of result with both schedules. With the FR schedule, the highest doses of 
both nomifensine and cocaine maintained less rapid rates, sometimes drama- 
tically less rapid rates, than the lower doses. This has been interpreted, not as 
a decrease in the reinforcing effect of the higher doses, but as a direct effect 
of the drug on self-injection responding. This direct effect can be lessened by 
increasing the amount of time between available infusions; thus, high rates of 
responding are maintained at even higher doses [ 51. 
The PR dose-effect curve for cocaine duplicated closely the FR dose-effect 
curve. The breaking points did not rise quite as rapidly with increasing doses 
as did the FR rates, and the decrease in rates at the highest dose was not as 
profound. This difference in result for the two schedules may have been 
produced by the larger increases in inter-injection times associated with the 
progressive-ratio schedule. The same dose (0.32 mg/kg per injection) main- 
tained the maximum rates under both conditions. This result confirms data 
of Griffiths et al. [5] using much longer procedures with both the PR and 
PR procedures. 
With nomifensine however, rates continued to increase across the tested 
doses in the PR procedure, even though a decrease in rates was observed in 
the highest dose under the FR procedure. In this respect, the data with nomi- 
fensine are similar to those of Griffiths et al. [3]. They noted a more dramatic 
reduction in breaking points at high doses with diethylpropion and chlor- 
phentermine than with cocaine and attributed this effect to the much shorter 
duration of action of cocaine than the other stimulants. Thus, during the 3-h 
TO following each drug infusion in the Griffiths’ et al. study, the cocaine 
effects may have dissipated more completely than those of diethylpropion or 
chlorphentermine. In a subsequent study, using higher doses of cocaine, a 
more convincing reduction in breaking points was demonstrated [ 51. If 
nomifensine is a short-acting drug, it might be possible to explain the lack of 
downturn at the highest dose under the PR condition by the fact that the PR 
schedule typically allows more time between drug infusions, thus giving the 
drug more opportunity to be inactivated, and reducing the direct rate-reducing 
effects of the drug on subsequent opportunities to respond. Data on the 
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pharmacokinetics of nomifensine indicate that it does have a short half life 
(approx. 2 h following oral administration), but that the EEG effects of the 
drug persist for several hours after it has been cleared from the blood. A 
metabolite of nomifensine was inactive and short-lived as well and cannot 
account for this peculiar prolonged effect [ 131. Thus, the reason why nomi- 
fensine does not show a decreased breaking point is unclear but, consistent 
with the interpretation of others, may reflect a relative short duration of 
action or less strong direct effects. Nevertheless, taken together, the two 
schedules, with both cocaine and nomifensine, produced similar effects. It 
would appear, under these circumstances, that PR and FR schedules may be 
controlled by similar processes. When apparent differences occur with the 
two schedules, it may be that widely different scheduled-controlled histories 
or temporal differences in controlling factors (e.g. dissipation of direct effects 
of self-injected drug) are contributing to these differences in result. 
These data indicate that FR schedules may provide data on the relative re- 
inforcing effects of drugs that are not markedly different from those obtained 
with a PR schedule. They also indicate that stable measures of PR breaking 
points can be obtained relatively rapidly, in a matter of hours rather than 
over the course of days as has been previously described. This evaluation of 
PR and FR schedules of reinforcement could be extended to a variety of 
compounds with different profiles and presumably different reinforcing 
strengths. This could enhance the generality of our findings of little difference 
between the two schedules. 
Studies in normal humans indicate that a single lOO-mg dose of nomifen- 
sine, given orally, did not produce euphoria or subjective effects that are in 
any way different from those following placebo. In the same subjects, 15 mg 
amphetamine produced marked mood elevation [ 131. These data, plus the 
fact that no abuse problems have arisen with nomifensine over several years 
of clinical use in Europe, stand in interesting opposition to the data in animals 
showing the strong reinforcing effects of this drug, comparable in efficacy to 
cocaine. Although the differences may lie in the route of administration, 
with less reinforcing capacity present in the orally administered compound, 
the rapid onset of action following oral dosing suggests that this may not be 
the entire answer. The data presented here indicate that nomifensine, should 
it become available in the United States, should be monitored very carefully 
for instances of abuse. Also, further research with this compound is certainly 
called for to help in the interpretation of discrepancies between human and 
animal experimental results. 
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